Federal Food and Nutrition Grants

The United States Department of Agriculture (USDA) Food and Nutrition Service (FNS) works to end hunger and promote nutrition security. The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) is a Federal nutrition assistance program that serves pregnant, postpartum, and breastfeeding individuals, infants, and children up to five years old who are income eligible and at nutritional risk. WIC provides nutritious foods, nutrition education including breastfeeding promotion and support, and referrals to health and social services to participants in all 50 geographic states, the District of Columbia, 33 Indian Tribal Organizations (ITOs), and five U.S. territories (American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, Puerto Rico, and the U.S. Virgin Islands). The Consolidated Appropriations Act, 2024 (The Act) (P.L. 117-2) provided the USDA with an appropriation to carry out the WIC Program as authorized by section 17 of the Child Nutrition Act of 1966 (CNA) (42 U.S.C. 1786). ARPA provided the USDA with $390 million to carry out outreach, innovation, and program modernization efforts to increase participation and redemption of benefits in WIC and the WIC Farmers Market Nutrition Program (FMNP). This is an announcement of the availability of funds for a one-time initiative, competitive cooperative agreement for up to four years. Funds are available to an entity (i.e., a civic technology nonprofit or other nonprofit type with similar staffing and experience/expertise; a research institute that is public, private, or nonprofit; or an accredited college or university) that meets the technical requirements outlined in this RFA. USDA anticipates awarding up to $15,000,000 to one selected applicant. The Period of Performance will be at a minimum two Fiscal Years will not exceed a maximum of four Fiscal Years.

This initiative provides funding to U.S.-based community organizations and agencies to develop and implement effective solutions that reduce menthol cigarette use among high-risk populations, including youth, LGBTQ+ communities, and racial and ethnic minorities.

This grant provides funding to small and intermediate beef processing businesses in the U.S. to expand their operations and improve market competition in the beef industry.

FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, companion animals (dogs, cats, and horses), and minor species (e.g., fish, sheep, goats) and 2) contribute to the development of data collection frameworks, including providing data and expertise as resources and a public-private partnership frameworks are established. This grant will support the continued advancement of FDA;apos;s initiatives to support antimicrobial stewardship in veterinary settings. It will also support the National Action Plan objectives to engage the animal health community and relevant stakeholders to advance strategies intended to improve understanding of antimicrobial use and foster antimicrobial stewardship in animal agriculture.

This funding opportunity supports researchers in planning high-risk, multi-center clinical studies focused on kidney, digestive, diabetes, and metabolic disorders, helping them develop essential protocols and administrative frameworks before conducting the actual trials.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each diastereomer in LEQVIO through stereo chemically controlled synthesis and biological activity assessment using in vitro and animal models. The proposed studies will focus on 1) synthesis of each diastereomer of LEQVIO (Inclisiran) in stereo chemically pure form; 2) assessment of the biological activity of each stereo chemically pure diastereomer in inhibiting PCSK9 activity using in vitro assays and in a transgenic mouse model; 3) development of analytical methods to identify and characterize the stereochemical structure of each diastereomer in LEQVIO; and 4) assessment of the individual contribution of each diastereomer to the overall pharmacological activity of LEQVIO. Tools developed in this research can also be applied to other similar GalNAc-conjugated siRNAs specifically, and other siRNAs in general. Knowledge gained from this research will also contribute to the sameness evaluation of generic siRNAs, and to the quality control of oligonucleotide drugs.

This funding opportunity supports a variety of organizations in developing and expanding local food systems that connect producers to consumers, enhancing access to local foods and improving economic opportunities for multiple stakeholders.

This grant provides funding to nonprofit organizations, academic institutions, and government entities to develop innovative solutions that improve access to legal resources and services for underserved rural communities across the United States.

ICN GE

This funding opportunity provides financial support for organizations to host conferences and scientific meetings that address important public health issues relevant to the FDA's mission.

This funding opportunity supports predoctoral students in dual-degree programs at institutions without NIH-funded training programs, helping them pursue research and clinical training to become future physician-scientists.

This grant invites private sector companies and organizations to collaborate with USAID on projects that address economic growth, financial inclusion, and environmental sustainability, leveraging their resources and expertise to achieve shared development goals.

This funding opportunity supports the development of innovative tools and technologies aimed at advancing research and treatment in kidney, urologic, and hematologic diseases, encouraging projects that push scientific boundaries and have broad applications beyond individual research interests.

This funding opportunity provides significant financial support to U.S. colleges and universities for research and development projects aimed at improving global food security and nutrition through innovative agricultural practices.

This funding opportunity provides financial support to federally recognized Indian Tribes and tribal organizations to implement community service initiatives that address pressing challenges and promote civic engagement, education, and cultural preservation within Native communities.

This funding opportunity provides $250,000 to a non-profit organization focused on breastfeeding education to develop training materials and enhance the skills of WIC staff nationwide.

The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The proposed work directly supports the U.S. FDAs stated goal of protecting public health from unacceptable risks from nitrosamine impurities in human drugs. Although significant experimental and policy/regulatory initiatives have been undertaken in this area, there remains a need for further research into and development and refinement of translational and implementable practices that will protect the public against nitrosamine risks while ensuring continued safe access to critical therapeutic drugs. The aim is to improve the safety of human drugs with potential nitrosamine impurity liabilities. In addition to the work outlined above, the award recipient will assess how best to ensure that this research and practices development continues among industry members, non-profits, and/or academic institutions once the FDA funding for this cooperative agreement ends.

This funding opportunity provides financial support to Tribes, Tribal organizations, and Urban Indian organizations to create programs that connect healthcare providers with food systems, enabling eligible participants to receive prescriptions for nutritious foods to combat food insecurity and improve health outcomes.

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative multidisciplinary and multi-level research designed to develop and/or test interventions to optimize care of persons with Type 2 diabetes from populations with health/health care disparities concordant with evidence-based guidelines. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations. Proposed projects would be expected to develop and/or test patient-centered strategies, which in addition to optimal glycemic control, would aim at completing other recommended guidelines (e.g., annual eye/foot and urine albumin exam, optimal blood pressure control, intake of ACEIs or ARBs/statin/aspirin and influenza/pneumonia vaccines).